Risk for drug discontinuation higher due to ineffectiveness, adverse events for MTX, CsA versus dupilumab

Sensitive skin occurred on body sites that were and were not affected by hyperhidrosis

Benzene concentrations detected in 111 over-the-counter BPO drug products that were tested, maintained at room temperature

Melanoma less common among racial and ethnic minorities, but they still have increased rate of second primary melanoma

DSS similar with Mohs micrographic surgery, wide local excision treatment; findings persist in adjusted analysis

Serum and tissue levels of CXCL9 are reduced after 12 weeks of narrowband ultraviolet B phototherapy

Clinically meaningful efficacy outcomes observed at one year maintained to two years of treatment

Long-term efficacy seen for lebrikizumab every two weeks or every four weeks in moderate-to-severe atopic dermatitis

Specific antibodies against three tumor antigens identified as promising diagnostic biomarkers for early-stage melanomas

Factors associated with in-hospital mortality include age, history of cancer, dementia, liver disease, EN severity

VisualDX demonstrated significantly greater sensitivity for Fitzpatrick I to III subgroup than Fitzpatrick IV to VI and a processed image subgroup

For plaque or guttate psoriasis, home-based phototherapy noninferior to office-based phototherapy for PGA and DLQI

Standardized incidence ratios elevated for all nonkeratinocyte skin cancers, melanoma

Semaglutide added to standard treatments yields improvement in quality of life, reduction in flares

Total yield rate lower, but not significantly so, on ARTAS side, and total transection rate also lower

When the precise location of a nonmelanoma tumor is uncertain, surgeons consider multiple elements of available data

Continued survival benefit seen for nivolumab plus ipilimumab and for nivolumab monotherapy versus ipilimumab monotherapy

Approval is for new, first-line biologic treatment of eczema that is not well controlled with topicals in people 12 years and older

Primary end point achieved by significantly more patients treated with roflumilast versus vehicle cream

Worse locoregional control, distant metastasis-free survival seen for CHNM versus cutaneous melanoma of other sites

Melanoma incidence highest on trunk in men; incidence historically highest on limbs in women, but recent increases seen in truncal melanoma

Mean value of SALT score decreased from average of 96.6 to 48 after 24 weeks of treatment

Studies on sunburn from last 20 years show positive significant odds ratios ranging from 1.23 to 8.48